GuiZhou SanLi Pharmaceutical Co.,Ltd (603439.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 4.92B |
| Enterprise Value | 5.23B |
| P/E Ratio | 123.54 |
| PEG Ratio | -1.53 |
| Price/Sales Ratio | 3.55 |
| Price/Book Ratio | 4.02 |
| Enterprise/Revenue | 3.82 |
| Enterprise/EBITDA | 45.9 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.03 |
| Operating Margin | 0.04 |
| Return On Assets | 0.02 |
| Return On Equity | 0.03 |
| Revenue | 1.7B |
| Revenue/Share | 4.15 |
| Gross Profit | 1.19B |
| EBITDA | 152.9M |
| Net Income | 46.25M |
| Diluted EPS | 0.11 |
| Total Cash | 376.3M |
| Total Cash/Share | 0.93 |
| Total Debt | 647.82M |
| Total Debt/Equity | 0.43 |
| Current Ratio | 1.57 |
| Book Value Per Share | 3.87 |
| 52-Week Change | 26.17 |
| 52-Week High | 17.46 |
| 52-Week Low | 10.49 |
| Moving Average 50 Days | 13.15 |
| Moving Average 200 Days | 12.32 |
| Average Volume | 12.56M |
| Shares Outstanding | 401.06M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.34 |
| Trailing Annual Dividend Yield | 2.29 |
| Payout Ratio | 3.17 |
| Last Split Factor | N/A |
| Last Split Date | N/A |